The Globe and Mail reports in its Friday, Feb. 9, edition that BMO Capital analyst Sohrab Movahedi has reaffirmed his "outperform" recommendation for Brookfield. The Globe's David Leeder writes in the Eye On Equities column that Mr. Movahedi gave his share target a $2 boost to $44 (all figures U.S.). Analysts on average target the shares at $49.27. Mr. Movahedi says in a note: "The key takeaway from Q4 results is that Brookfield expects to repurchase at least $1-billion in stock over the next few months, an acceleration from $600-million throughout 2023. 2024 earnings growth prospects appear favorable with the continued scaling of asset management and insurance earnings alongside potential for improving real estate fundamentals. The net result is Brookfield's discount to NAV has narrowed to 15 per cent, an improvement from 40 per cent a year ago." The Globe reported on Nov. 10 that Scotia Capital analyst Mario Saric was keeping his "sector perform" recommendation for Brookfield intact. The shares could then be had for $32.19. The Globe reported on Jan. 5 that RBC Dominion Securities analyst Robert Kwan continued to rank Brookfield "outperform." The shares could then be had for $38.52.